Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

8.99
+0.37004.29%
Volume:156.49K
Turnover:1.41M
Market Cap:297.40M
PE:-10.72
High:9.17
Open:8.65
Low:8.65
Close:8.62
52wk High:18.98
52wk Low:5.45
Shares:33.08M
Float Shares:22.52M
Volume Ratio:0.57
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8387
EPS(LYR):-0.9318
ROE:-176.94%
ROA:-12.39%
PB:15.30
PE(LYR):-9.65

Loading ...

Wolfe Research Reaffirms Their Buy Rating on NeuroPace (NPCE)

TIPRANKS
·
Aug 14

NeuroPace, Inc. (NASDAQ:NPCE) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St.
·
Aug 14

NeuroPace’s Strategic Advancements and Revenue Growth Underpin Buy Rating Despite Challenges

TIPRANKS
·
Aug 14

NeuroPace Q2 2025 Earnings Call Summary and Q&A Highlights: Record Revenue, Strategic Guidance Updates, and Clinical Progress

Earnings Call
·
Aug 13

NeuroPace (NPCE) Q2 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Aug 13

NeuroPace reports Q2 EPS (26c), consensus (22c)

TIPRANKS
·
Aug 13

NeuroPace: On track to submit Nautilus data to FDA in 2H

TIPRANKS
·
Aug 13

NeuroPace raises FY25 revenue view to $94M-$98M, consensus $94.78M

TIPRANKS
·
Aug 13

NeuroPace Q2 EPS $(0.26) Misses $(0.23) Estimate, Sales $23.52M Beat $23.09M Estimate

Benzinga
·
Aug 13

NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

GlobeNewswire
·
Aug 13

NeuroPace (NPCE) Gets a Buy from Lake Street

TIPRANKS
·
Aug 11

Neuropace Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
Aug 09

BRIEF-Neuropace To Continue To Work With CMS On MS-Drg Improvements

Reuters
·
Aug 01

Neuropace Inc - to Continue to Work With CMS on MS-Drg Improvements

THOMSON REUTERS
·
Aug 01

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases

GlobeNewswire
·
Aug 01

NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025

GlobeNewswire
·
Jul 30

NeuroPace (NPCE) Receives a Buy from Leerink Partners

TIPRANKS
·
Jun 26

Wells Fargo Sticks to Their Buy Rating for NeuroPace (NPCE)

TIPRANKS
·
Jun 25

NeuroPace Appoints New CFO Amid Strategic Shift

TIPRANKS
·
Jun 25

NeuroPace CFO Rebecca Kuhn to depart, Patrick Williams to succeed

TIPRANKS
·
Jun 25